Mature cardiologists should never trust BMS !
This study done with over 9000 patients concluded like this . . .
The DES industry was (is) so powerful it could easily shrug the challenge of truth that came out briefly in early 2000s when DES got hit with increased acute complications.
Now, in 2016 NORSTENT study again showed us BMS is as good as DES in all walks of CAD. Let us see what happens , still its very unlikely mature cardiologists do not trust BMS.
*I have a belief (Paranoid or not time will tell !) one of the reasons DES are strongly promoted is to sustain DAPT market alive and kicking for a long haul !
Scenerio in India is frightening.
While the developed countries have DES usage rate around 65 % , India leads the world with DES constituting 95% (NIC registry 2017) of all deployed stents.What a way for a poor country to tackle CAD , which doesn’t even have prompt prehospital Aspirin for bulk of their ACS patients, ready to waste its resources in DES.
India , a country Infested with a unregulated health industry became the perfect battle ground for abusing the stents. With direct collusion with the large hospital managements the issue got exploded recently .The Govt was compelled to come out with urgent restrictions and price control in the use of stents.
Funny world this. World’s richest economies are worried about the cost and want to phase out inappropriate therapy whenever possible, its absolute arrogance most of us feel shamed to keep BMS in their ca...
Source: Dr.S.Venkatesan MD - Category: Cardiology Authors: dr s venkatesan Tags: cost effectiveness in cardiology Ethics in Medicine innovations in cardiology Newer hardwares in cardiology Technology Emerging bms vs des malapposition of stent norstent Source Type: blogs
More News: Aspirin | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Heart | Hospital Management | Hospitals | Medical Ethics | Study | Thrombosis